skip to main content
European Commission Logo
en English
Newsroom

Overview    News

Investment Plan: EU invests in drug research, AI, and blockchain technology, as well as wind energy and SMEs

The European Investment Bank (EIB) announced on 30 October that it will provide Minoryx Therapeutics with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases for which there are currently no approved drugs available.

date:  05/11/2020

See alsoInvestment Plan for Europe

The EIB financing is backed by the European Fund for Strategic Investments (EFSI), the financial pillar of the Investment Plan for Europe, the Juncker Plan. On 28 October, the European Investment Fund (EIF) and the Commission announced the first 6 Venture Capital funds under the InnovFin Artificial Intelligence and Blockchain pilot. New agreements with tech equity funds in Austria, Finland, Germany, Luxembourg and the Netherlands are expected to bring €700 million to tech companies across Europe. Meanwhile, the EIB and Landesbank Baden-Württemberg are providing PLN 184 million (approximately €42 million) each to finance the construction and operation of four wind farms in Poland's Wielkopolskie region. In Spain, the EIB is joining forces with Santander to provide financing on favourable terms to Spanish SMEs and mid-caps affected by the economic impact of COVID-19. The EIB and the EIF will subscribe several tranches of a synthetic securitisation of an SME loan portfolio originated by Banco Santander, enabling the Spanish bank to provide more than €900 million in financing to support SMEs.